Management Team

Dr. David M. Milch

Chairman & Director

  • 30+ years of Global Business Experience in Healthcare
  • A Founder, Leader, Investor in Life Sciences, Technology and Medical Devices
  • A visionary leader and Investor in Technology and Life Sciences including Heart Guard (start-up), American Blood Institute (private sale), Intelligent Medical Imaging (IPO), Biofield (IPO), Nitinol (IPO), Datatec Systems (reverse merger), Warp Technologies (reverse merger), MiniMed (acquired by Medtronic), Advanced Bionics (acquired by Boston Scientific), Theravance (IPO), Contrafect (IPO) Alpha Tau (private equity), Wisdo (private equity), Cyteir Therapeutics (private equity), Serpin Pharma (private equity) and Games 24×7 (private equity).
  • Founder and Chairman of AllMed Solutions LTD, a public medical device technology company based in Israel.

William Johns

Chief Executive Officer and Director

  • 30+ years of Global Business Experience in Healthcare Technology & Investment Banking
  • An Entrepreneur, Leader of Private & Public Companies in Technology and Investment Banking: Salomon Brothers, Citigroup, Fox-Pitt, Kelton, Swiss Re, National Provider Network LLC
  • Expertise in the development of advanced software applications to improve the efficiency of care delivery, accurate reimbursement, and maintenance of medical records.
  • A former investment banker with global business experience and financial institution relationships.
  • Skilled in executing significant, complex acquisitions and financing transactions, efficiently leading multi-party projects with strategy, operations, accounting, tax, and regulatory dimensions.

Philip Baseil

Chief Financial Officer

  • 30+ years of Global Business Experience in Healthcare Driving Profitable Growth B2B & B2C
  • An Entrepreneur, A leader in Private & Public Fortune 500 Companies: Tradex a Cardinal Health Company, Tradex International Inc., Henry Schein Inc., Driving Profitable Growth LLC
  • High impact and strategic leader known for delivering top and bottom-line results in privately held and Fortune 500 companies via deployment of exceptional relationship building, financial management, operational efficiency and strategic vision within healthcare, retail, wholesale and pharmaceutical space.
  • Trusted leader to boards, executive management, and internal peers, and is experienced in identifying opportunities for mergers, acquisitions, new product introduction, go-to-market strategies, and production efficiency in the most highly competitive private and public industry segments.